Zhou, Xin
Jilin University · First Hospital of Jilin University
7 papers on CoChatORCID 0000-0002-9362-8272
Most cited papers
- Verified
The Hippo Tumor Pathway Promotes TAZ Degradation by Phosphorylating a Phosphodegron and Recruiting the SCFβ-TrCP E3 Ligase
Liu, C.-Y., Zha, Z.-Y., Zhou, X., Zhang, H., Huang, W., Zhao, D., Li, T., Chan, S. W., Lim, C. J., Hong, W., et al. (2010) · Journal of Biological Chemistry
Hippo pathway signaling and YAP/TAZUbiquitin and proteasome pathways
Cited by 525
- Verified
Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth
Lin, R., Tao, R., Gao, X., Li, T., Zhou, X., Guan, K.-L., Xiong, Y., & Lei, Q.-Y. (2013) · Molecular Cell
Cancer, Lipids, and MetabolismLipid metabolism and biosynthesis
Cited by 384
- Verified
Estrogen regulates Hippo signaling via GPER in breast cancer
Zhou, X., Wang, S., Wang, Z., Feng, X., Liu, P., Lv, X.-B., Li, F., Yu, F.-X., Sun, Y., Yuan, H., et al. (2015) · Journal of Clinical Investigation
Hippo pathway signaling and YAP/TAZEstrogen and related hormone effects
Cited by 232
- Verified
USP21 deubiquitinase promotes pancreas cancer cell stemness via Wnt pathway activation
Hou, P., Ma, X., Zhang, Q., Wu, C.-J., Liao, W., Li, J., Wang, H., Zhao, J., Zhou, X., Guan, C., et al. (2019) · Genes & Development
Ubiquitin and proteasome pathwaysPancreatic and Hepatic Oncology Research
Cited by 96
- Verified
YAP1 oncogene is a context-specific driver for pancreatic ductal adenocarcinoma
Tu, B., Yao, J., Ferri-Borgogno, S., Zhao, J., Chen, S., Wang, Q., Yan, L., Zhou, X., Zhu, C., Bang, S., et al. (2019) · JCI Insight
Hippo pathway signaling and YAP/TAZPancreatic and Hepatic Oncology Research
Cited by 75
- Verified
USP21 deubiquitinase elevates macropinocytosis to enable oncogenic KRAS bypass in pancreatic cancer
Hou, P., Ma, X., Yang, Z., Zhang, Q., Wu, C.-J., Li, J., Tan, L., Yao, W., Yan, L., Zhou, X., et al. (2021) · Genes & Development
Pancreatic and Hepatic Oncology ResearchUbiquitin and proteasome pathways
Cited by 35
- Verified
YAP/TAZ mediates resistance to KRAS inhibitors through inhibiting proapoptosis and activating the SLC7A5/mTOR axis
Yang, W., Zhang, M., Zhang, T.-X., Liu, J.-H., Hao, M.-W., Yan, X., Gao, H., Lei, Q.-Y., Cui, J., & Zhou, X. (2024) · JCI Insight
Hippo pathway signaling and YAP/TAZProtein Kinase Regulation and GTPase Signaling
Cited by 31
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free